Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AC Immune S.A. (NQ: ACIU )

3.200 +0.100 (+3.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 168,783
Open 3.080
Bid (Size) 3.000 (1)
Ask (Size) 3.300 (1)
Prev. Close 3.100
Today's Range 3.080 - 3.270
52wk Range 2.460 - 12.61
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: AC Immune Q1 Earnings
AC Immune (NASDAQ:ACIU) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
AC Immune: Q4 Earnings Insights
AC Immune (NASDAQ:ACIU) reported its Q4 earnings results on Tuesday, March 22, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings AC... 
Via Benzinga

Performance

YTD
-37.98%
-37.98%
1 Month
-15.12%
-15.12%
3 Month
-30.74%
-30.74%
6 Month
-43.26%
-43.26%
1 Year
-49.76%
-49.76%

More News

Read More
The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill
Via Benzinga
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
Via Benzinga
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm
Via Benzinga
Mid-Afternoon Market Update: Spok Holdings Surges On Takeover Offer; Sequential Brands Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
76 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
ACIU Stock: The Big Alzheimer’s News That Has AC Immune Skyrocketing Today
Via InvestorPlace
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Via Benzinga
Exposures COVID-19
Mid-Day Market Update: Zoom Shares Drop After Q2 Results; AC Immune Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
33 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
Here's Why AC Immune Stock Is Surging Today
Via The Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Via Benzinga
Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Via Benzinga
Why A Roche-Partnered Alzheimer's Drug Sent AC Immune Stock Flying
Via Investor's Business Daily
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
Via Benzinga
55 Biggest Movers From Yesterday
Via Benzinga
AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate
Via Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Via Benzinga
Exposures Product Safety
75 Biggest Movers From Yesterday
Via Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.